Reminder - First Trust High Income Long/Short Fund (FSD) Goes Ex-Dividend Soon

Looking at the universe of stocks we cover at Dividend Channel, on 7/1/15, First Trust High Income Long/Short Fund (FSD) will trade ex-dividend, for its monthly dividend of $0.1065, payable on 7/15/15. As a percentage of FSD's recent stock price of $15.49, this dividend works out to approximately 0.69%, so look for shares of First Trust High Income Long/Short Fund to trade 0.69% lower — all else being equal — when FSD shares open for trading on 7/1/15.

START SLIDESHOW:
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »

Below is a dividend history chart for FSD, showing historical dividends prior to the most recent $0.1065 declared by First Trust High Income Long/Short Fund:

FSD+Dividend+History+Chart

In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from FSD is likely to continue, and whether the current estimated yield of 8.25% on annualized basis is a reasonable expectation of annual yield going forward. The chart below shows the one year performance of FSD shares, versus its 200 day moving average:

First Trust High Income Long/Short Fund 200 Day Moving Average Chart

Looking at the chart above, FSD's low point in its 52 week range is $15.37 per share, with $18.19 as the 52 week high point — that compares with a last trade of $15.57.

In Monday trading, First Trust High Income Long/Short Fund shares are currently down about 1% on the day.

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says